Skip to content | Change text size

BMC3105

Emerging Technologies in Drug Discovery ( 6 points, SCA Band 2, 0.125 EFTSL)

Undergraduate
(PHA)

Leader: Dr Ian Crosby and Dr Don McNaughton

Offered:
Parkville Second semester 2005 (Day)

Synopsis: This unit introduces the participants to a number of recently emerged, or emerging, technologies that have proven utility or have the potential to be useful in medicinal chemistry. The unit is designed to update itself by requiring at least 1/6 of the course to be changed annually and/or critically reviewed as to it being a currently emerging technology. This years focus will be on synchrotron science and in particular the synchrotron resources that will be available on the Australian synchrotron scene.

Assessment: Exam: 70%; Assignment: 30%